February 21st 2011
Alexander Kel, CSO of geneXplain, presented at the ABRF2011 in San Antonio, Texas.
In a workshop on the “Identification of Mechanism-Based Biomarkers and Drug Targets Using Pathway Analysis”, Alexander has spoken about “GeneXplain — Identification of Causal Biomarkers and Drug Targets in Personalized Cancer Pathways”